Ahead of the G7 Summit on 26-27 May in Ise-Shima, Japan and following on from the meeting in April (23-24) of the agricultural ministers of the G7, Europe’s animal health industry is urging the leaders of the G7 summit to consider a holistic One Health approach in dealing with antimicrobial resistance (AMR) and infectious diseases. In so doing, the animal health sector in Europe seeks to remind policy-makers that AMR concerns not only human and public health, but also animal health.
The final report of the O’Neill Review on Antimicrobial Resistance (AMR), released today, overall makes some good recommendations in terms of encouraging innovation for the quick development of new diagnostics, promoting the use of vaccines and alternatives to antibiotics, improving surveillance of AMR and antibiotic consumption in both people and animals, as well as endorsing better incentives to encourage investment for new medicines and improving existing ones, as well as the setting up of a Global Innovation Fund.
Brussels, 8 April 2016 – The European Medicines Agency has launched its new European Surveillance Veterinary Antimicrobial Consumption project’s (ESVAC) vision and strategy document 2016-2020. IFAH-Europe is pleased to note that ESVAC will be looking at the use of antibiotics in different animal species for the first time, which should enable policy-makers to develop better targeted and refined policies to fight AMR (antimicrobial resistance) effectively.
The recently-published Eurobarometer on Consumer Attitudes towards Animal Welfare shows that animal welfare continues to be a highly important issue for most EU citizens. Animal health is a precursor to animal welfare, and veterinary medicines are a key component to achieving the well-being of animals, both on farm and in the home.